DS-5141b

· Daiichi Sankyo Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DS-5141b, covering 2024-03-07 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy [Phase 2]